[{"Assets_0_Q2_USD":109212000.0,"CommonStockSharesOutstanding_0_Q2_shares":163053000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-11182000.0,"NetIncomeLoss_1_Q2_USD":-2226000.0,"NetIncomeLoss_2_Q2_USD":-7765000.0,"StockholdersEquity_0_Q2_USD":41552000.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]